GlassScriptPhysician profile
James Mcwhorter
NPI 1467422295
$1,265.52
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $228 · 2021: $229 · 2022: $192 · 2023: $326 · 2024: $34.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.60 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $401.15 | 2019-2022 | |
| Astellas Pharma US INC | $205.99 | 2023-2024 | Veozah, Myrbetriq |
| Avion Pharmaceuticals | $175.49 | 2021-2023 | Balcoltra |
| Lupin INC. | $146.21 | 2019-2021 | |
| Pfizer INC. | $116.47 | 2019-2023 | |
| Organon LLC | $63.52 | 2021-2023 | Nexplanon |
| Exeltis, USA INC. | $45.28 | 2022-2023 | Slynd, Solosec |
| Agile Therapeutics, INC. | $31.17 | 2022-2023 | Twirla |
| Evofem Biosciences, INC. | $28.82 | 2021 | |
| Daiichi Sankyo INC. | $17.62 | 2021 | |
| Roche Diagnostics Corporation | $16.94 | 2019 | |
| Shield Therapeutics INC | $16.86 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcwhorter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.